Insights from 2023 ASCO® Annual Meeting
Playback speed
10 seconds
ASCO® 2023 Insights: "10-Year Update of the Short-HER Phase III Randomized Trial - Nine-Weeks vs. One-Year Trastuzumab for Early-Stage HER2+ BC"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Pierfranco Conte
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Pierfranco Conte
760 views
June 15, 2023
Comments 0
Login to view comments.
Click here to Login
Breast